Rationale, design, and conduct of the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions.

Author: BushT L, EspelandM A, JohnsonS, Mebane-SimsI, SherwinR, StefanickM L, WaclawiwM

Paper Details 
Original Abstract of the Article :
There is growing and consistent evidence that estrogen use in postmenopausal women is associated with a substantial reduction in the occurrence of cardiovascular disease. However, remarkably little is known about the biological mechanisms by which estrogen therapy may influence risk. Even less infor...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0197-2456(94)00033-y

データ提供:米国国立医学図書館(NLM)

PEPI Trial: Unveiling the Impact of Estrogen and Progestin on Cardiovascular Health

This paper provides a detailed overview of the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial, a groundbreaking study designed to investigate the effects of estrogen and estrogen-progestin therapy on cardiovascular risk factors in postmenopausal women. The authors, like meticulous researchers meticulously planning an expedition through the complex terrain of women's health, designed this large-scale trial to understand the impact of hormonal therapy on multiple biological systems. They aimed to provide valuable insights into the potential benefits and risks of estrogen and estrogen-progestin therapy, guiding clinical practice and informing patient decisions.

Uncovering the Complexities of Hormonal Therapy

The PEPI Trial, akin to a monumental desert expedition, sought to unravel the complex interplay between hormonal therapy and cardiovascular health. The authors recognized the need for a large-scale study to address the limitations of existing research and provide a more comprehensive understanding of the potential effects of estrogen and progestin therapy. They aimed to investigate the impact of these hormones on a range of biological systems, including the cardiovascular, skeletal, and metabolic systems.

Guiding Clinical Practice and Patient Choices

The findings of the PEPI Trial, like a valuable treasure discovered in the desert, hold the potential to guide clinical practice and inform patient choices regarding hormonal therapy. The study's results will provide valuable insights into the risks and benefits of estrogen and estrogen-progestin therapy, empowering women to make informed decisions about their health and well-being.

Dr. Camel's Conclusion

The PEPI Trial represents a significant contribution to the field of women's health, offering valuable insights into the impact of hormonal therapy on cardiovascular health. The authors' meticulous design and comprehensive approach, akin to a well-planned desert expedition, provide a solid foundation for understanding the complex relationship between hormones, cardiovascular risk factors, and overall health. The study's findings will undoubtedly guide clinical practice and empower women to make informed decisions regarding their health.

Date :
  1. Date Completed 1995-12-12
  2. Date Revised 2019-10-23
Further Info :

Pubmed ID

7587218

DOI: Digital Object Identifier

10.1016/0197-2456(94)00033-y

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.